$Part 11- Management of Relapsed Refractory Multiple Myeloma:Noval Treatment Options- Dr Uday$

Part 11- Management of Relapsed Refractory Multiple Myeloma:Noval Treatment Options- Dr Uday

18:18 |

Related Videos

Part 2- Sexual Activity and Vaginal Functioning in Patients with Advanced Cervical Cancer- Dr Shipra

5:47

Part 2- Sexual Activity and Vaginal Functioning in Patients with Advanced Cervical Cancer- Dr Shipra

Hall D - Day 2, Fortis Cancer Summit 2024

9:49:59

Hall D - Day 2, Fortis Cancer Summit 2024

Hall A - Day 1, Fortis Cancer Summit 2024

8:09:02

Hall A - Day 1, Fortis Cancer Summit 2024

LIVER CANCER MASTERCLASS

2:57:54

LIVER CANCER MASTERCLASS

Changing Paradigm of Hyperphosphatemia in CKD: Role of Sucroferric Oxyhydroxide

2:17:27

Changing Paradigm of Hyperphosphatemia in CKD: Role of Sucroferric Oxyhydroxide

Webinar on the occasion of THE WORLD LYMPHOMA DAY

2:52:44

Webinar on the occasion of THE WORLD LYMPHOMA DAY

Circulating Tumor Cells 2.0 - OncoDiscover

5:08:54

Circulating Tumor Cells 2.0 - OncoDiscover

Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia

2:51:48

Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia

National Quiz on Bone & Soft Tissue Tumours

3:28:47

National Quiz on Bone & Soft Tissue Tumours

Part 3 - FOXO1 Inhibition as a Therapeutic Strategy for Radiation Fibrosis - Dr Shivani Mehra

6:26

Part 3 - FOXO1 Inhibition as a Therapeutic Strategy for Radiation Fibrosis - Dr Shivani Mehra

Live Webinar Managing Hair Loss with Scalp Cooling (for nurses)

1:57:25

Live Webinar Managing Hair Loss with Scalp Cooling (for nurses)

World Kidney Cancer Day

5:20

World Kidney Cancer Day

Part 14 - Panel Discussion: Optimal Management of High Grade B Cell Lymphomas - Dr Deepesh Lad

27:48

Part 14 - Panel Discussion: Optimal Management of High Grade B Cell Lymphomas - Dr Deepesh Lad

Part 2 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu

3:34

Part 2 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu

Part 2 - Quality Assurance of Contouring for NRG Oncology/RTOG 1308 Clinical Trial - Dr Sarthak

7:08

Part 2 - Quality Assurance of Contouring for NRG Oncology/RTOG 1308 Clinical Trial - Dr Sarthak

Recent Advances in Uro-Oncology

2:00:08

Recent Advances in Uro-Oncology

Part 13- Case Based Discussion on optimal sequencing of Anti HER2 therapies in HER2 +ve MBC- Dr Vaid

23:00

Part 13- Case Based Discussion on optimal sequencing of Anti HER2 therapies in HER2 +ve MBC- Dr Vaid

Part 3 - Precision Medicine for Relapsed Ovarian Cancer, Optimal use of Targeted agents - Dr Sandeep

20:20

Part 3 - Precision Medicine for Relapsed Ovarian Cancer, Optimal use of Targeted agents - Dr Sandeep

Part 4 - Update on stem cell tranplant in Myeloma -

22:08

Part 4 - Update on stem cell tranplant in Myeloma -

Part 5 - Immunotherapy in the maintenance treatment of all patients with Stage III NSCLC- Dr Manish

16:02

Part 5 - Immunotherapy in the maintenance treatment of all patients with Stage III NSCLC- Dr Manish